Key result
Obesity was not an independent risk factor for 30-day mortality after infective endocarditis surgery in multivariable analysis.
Why the study?
To investigate how body mass index affects outcomes in patients treated surgically for infective endocarditis.
Does body mass index (BMI) affect short- and long-term mortality and postoperative complications in patients treated surgically for infective endocarditis?
Cohort (n=650)
No
Does body mass index (BMI) affect short- and long-term mortality and postoperative complications in patients treated surgically for infective endocarditis?
In patients undergoing surgery for infective endocarditis, severe obesity (BMI >=35 kg/m2) is associated with higher rates of postoperative acute kidney injury, sternal wound infection, and unadjusted mortality, but is not an independent predictor of death after adjusting for age >60, LVEF <30%, Staphylococcus aureus infection, and prosthetic valve endocarditis.
Answers are grounded in this paper and cite their sources.
Obesity should not yet alter surgical risk stratification in infective endocarditis; leaves open its role in complications and long-term survival.
Objective: to investigate how body mass index (BMI) affects the outcome in patients treated surgically for infective endocarditis (IE). Methods: This is a single-center observational analysis of consecutive patients treated surgically for IE. We divided the cohort into six groups, according to the WHO classification of BMI, and performed subsequent outcome analysis. Results: The patient population consisted of 17 (2.6%) underweight, 249 (38.3%) normal weight, 252 (38.8%) overweight, 83 (12.8%) class I obese, 28 (4.3%) class II obese, and 21 (3.8%) class III, or morbidly obese, patients. The median age of the entire cohort was 64.5 [52.5–73.6] years. While only 168 (25.9%) patients were female, women significantly more often exhibited extremes in regards to BMI, including underweight (47.1%) and morbid obesity (52.4%), p = 0.026. Class II and III obese patients displayed more postoperative acute kidney injury (47.9%), p = 0.003, more sternal wound infection (12.9%), p < 0.001, worse 30-day survival (20.4%), p = 0.031, and worse long-term survival, p = 0.026, compared to the results for the other groups. However, the multivariable analysis did not identify obesity as an independent risk factor for 30-day mortality, with an odds ratio of 1.257 [0.613–2.579], p = 0.533. Rather, age > 60, reduced LVEF < 30%, staphylococcal infection, and prosthetic valve endocarditis correlated with mortality. While BMI showed poor discrimination in predicting 30-day mortality on the ROC curve (AUC = 0.609), it showed a fair degree of discrimination in predicting sternal wound infection (AUC = 0.723). Conclusions: Obesity was associated with increased comorbidities, complications, and higher postoperative mortality in IE patients, but it is not an independent mortality risk factor. While BMI is a poor predictor of death, it is a good predictor of sternal wound infections.
No takes yet. Share an insight, caveat, or question.
Elderia et al. (2024) conducted a cohort in Infective endocarditis treated surgically (n=650). Obesity (WHO BMI classification, specifically Class II and III obesity with BMI ≥35 kg/m²) vs. Normal weight / lower BMI groups was evaluated on 30-day all-cause mortality (multivariable analysis for obesity as an independent risk factor) (OR 1.257, 95% CI 0.613-2.579, p=0.533). Obesity was not an independent risk factor for 30-day mortality after infective endocarditis surgery in multivariable analysis.
Synapse has enriched 10 related papers. Consider them for comparative context: